Showing results (111-120 of 452) with videos related to

Sort By:
Pageof 46
Journal of the National Cancer Institute|February 26, 2011
An empirical evaluation of guidelines on prostate-specific antigen velocity in prostate cancer detectionAndrew J Vickers, Cathee Till, Catherine M Tangen, et al.
European Urology|December 22, 2018
Development and Validation of Crosswalks for Patient-reported Sexual and Urinary Outcomes Between Commonly Used InstrumentsKarandeep Singh, Amy L Tin, Rodney L Dunn, et al.
The Journal of Urology|July 21, 2015
Can Confirmatory Biopsy be Omitted in Patients with Prostate Cancer Favorable Diagnostic Features on Active Surveillance?Prassannah Satasivam, Bing Ying Poon, Behfar Ehdaie, et al.
European Urology|January 26, 2024
Amount of Gleason Pattern 3 Is Not Predictive of Risk in Grade Group 2-4 Prostate CancerAndrew J Vickers, Melissa Assel, Matthew R Cooperberg, et al.
BJU International|May 27, 2018
Effects of pathological upstaging or upgrading on metastasis and cancer-specific mortality in men with clinical low-risk prostate cancerEvan Kovac, Emily A Vertosick, Daniel D Sjoberg, et al.
Neuron Glia Biology|October 19, 2006
Overexpression of c-MYC promotes an undifferentiated phenotype in cultured astrocytes and allows elevated Ras and Akt signaling to induce gliomas from GFAP-expressing cells in miceAndrew B Lassman, Chengkai Dai, Gregory N Fuller, et al.
Medical Decision Making : an International Journal of the Society for Medical Decision Making|March 10, 2009
Long-term health outcomes of a decision aid: data from a randomized trial of adjuvant! In women with localized breast cancerAndrew J Vickers, Elena B Elkin, Pamela B Peele, et al.
Urology|March 4, 2014
A commentary on PSA velocity and doubling time for clinical decisions in prostate cancerAndrew J Vickers, Ian M Thompson, Eric Klein, et al.
Acta Oncologica (Stockholm, Sweden)|May 25, 2011
Tumor markers in prostate cancer I: blood-based markersShahrokh F Shariat, Axel Semjonow, Hans Lilja, et al.
Translational Andrology and Urology|July 23, 2021
Active surveillance for prostate cancerDaniela K Shill, Monique J Roobol, Behfar Ehdaie, et al.
Pageof 46